Healthcare
Live Price
Offline$0.0051
+0.00% today
1Y Change
-82.22%
Window
Jun 23, 2025 → May 29, 2026
Coverage: 236 bars · Jun 23, 2025 → May 29, 2026
Research Briefing
A compact read on the setup, peer context, quarterly changes, and recent earnings reaction.
Research Snapshot
StageZero Life Sciences Ltd. (SZLSF) is a Healthcare stock with listed on OTC. The stock last traded around $0.01 and down 82.2% across the available one-year price window (Jun 23, 2025 → May 29, 2026). Baseline metrics include revenue growth of -25.1%, EPS growth of -10.0%, a dividend yield of 0.0%. What stands out right now is revenue -25.1%, EPS -10.0%, free cash flow +61.2% with operating margin -204.1% and ROIC 151.8%. Valuation is more restrained than many high-expectation growth names at price/sales 0.2. Overall, the current profile looks closer to a turnaround or cyclical reset than a generic broad-market placeholder. Stock Foundry combines SZLSF price history, valuation, growth, dividend context, earnings, analyst forecasts, news, related Healthcare peers on this page.
Benchmark Comparison
Compare this ticker against a broad index, growth benchmark, or sector ETF using a shared 1Y normalization window.
SZLSF
—
Normalized return
SPY
—
S&P 500
Excess Return
—
Relative to SPY
SZLSF Max Drawdown
-98.26%
Trailing 1Y
SPY Max Drawdown
—
Trailing 1Y
Uses the longest available daily history for SZLSF and SPY.
Powered by FMP stock_dividend. Includes historical ex-dates, pay dates, and payout amounts.
Dividend Yield
No active yield
Trailing 12M Payout
$0.00
Last Payout
—
Next Step
Dividend yield means more when it is matched with payout durability, earnings quality, and sector context.